So far in 2023, pharmaceutical companies have raised prices on 988 brand-name drugs for an average 5 percent wholesale acquisition cost increase, according to 46brooklyn Research, a nonprofit that tracks drug pricing data.
This is the highest number of January drug price increases since 2011, its dashboard shows. More than 600 of them don't have generic alternatives.
The dashboard published list changes — not prices — and "it doesn't capture the variable, completely hidden and ever-growing rebates shuffling around in the dark," the research firm's website says. "But it's a start."